Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2564)
All Articles published online
|
Dec 15, 2001 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xie Q, Liu KD, Hu MY, Zhou K. SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma. World J Gastroenterol 2001; 7(6): 816-820 [PMID: 11854908 DOI: 10.3748/wjg.v7.i6.816] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i6/816.htm |
| Number | Citing Articles |
| 1 |
Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, Iekhsan Othman, Rakesh Naidu. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.772510
|
| 2 |
Zheng Wang, You-Bing Ruan, Yang Guan, Sheng-Hong Liu. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World Journal of Gastroenterology 2003; 9(2): 267-270 doi: 10.3748/wjg.v9.i2.267
|
| 3 |
Norihiko Sasaki, Masashi Toyoda, Toshiyuki Ishiwata. Gangliosides as Signaling Regulators in Cancer. International Journal of Molecular Sciences 2021; 22(10): 5076 doi: 10.3390/ijms22105076
|
| 4 |
Aroosha Raja, Farhan Haq. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. Journal of Cancer Research and Clinical Oncology 2022; 148(1): 15 doi: 10.1007/s00432-021-03826-w
|
| 5 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3323 doi: 10.1007/978-3-319-26956-6_181
|
| 6 |
Mei Hang Wei, Yi Xu, Dong Shun Li, Zhen Zhou. Study of the Microfluidic-Immunoassay Chip used to Capture Cancer Cells. Key Engineering Materials 2011; 483: 316 doi: 10.4028/www.scientific.net/KEM.483.316
|
| 7 |
Danqi Chen, Ying Wang, Yuchi Ma, Bing Xiong, Jing Ai, Yi Chen, Meiyu Geng, Jingkang Shen. Discovery of 3H‐Imidazo[4,5‐b]pyridines as Potent c‐Met Kinase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem 2012; 7(6): 1057 doi: 10.1002/cmdc.201200120
|
| 8 |
Michael J. Gray, Gary E. Gallick. Mechanisms of Oncogenesis. 2010; : 19 doi: 10.1007/978-90-481-3725-1_2
|
| 9 |
R. Kaufmann, C. Oettel, A. Horn, K.-J. Halbhuber, A. Eitner, R. Krieg, K. Katenkamp, P. Henklein, M. Westermann, F. D. Bohmer, R. Ramachandran, M. Saifeddine, M. D. Hollenberg, U. Settmacher. Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis 2009; 30(9): 1487 doi: 10.1093/carcin/bgp153
|
| 10 |
Aránzazu Sánchez, Isabel Fabregat. Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis. Clinical and Translational Oncology 2009; 11(4): 208 doi: 10.1007/s12094-009-0342-x
|
| 11 |
Yao Dai, Wenyin Shi, Nikolett Molnar, Dietmar Siemann. Signaling Pathways and Molecular Mediators in Metastasis. 2011; : 171 doi: 10.1007/978-94-007-2558-4_7
|
| 12 |
Armando Santoro, Eric Assenat, Thomas Yau, Jean-Pierre Delord, Michela Maur, Jennifer Knox, Stephane Cattan, Kyung-Hun Lee, Gianluca Del Conte, Christoph Springfeld, Elisa Leo, Alexandros Xyrafas, Lauren Fairchild, Feby Mardjuadi, Stephen L. Chan. A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma. JHEP Reports 2024; 6(4): 101021 doi: 10.1016/j.jhepr.2024.101021
|
| 13 |
Tanguy Y. Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, Varalakshmi Janamanchi, Vidya Nallasura, Mohamed El Dinali, Soheil Yala, Rajani Kanteti, Ezra E.W. Cohen, Mark W. Lingen, Leslie Martin, Soundararajan Krishnaswamy, Andres Klein-Szanto, James G. Christensen, Everett E. Vokes, Ravi Salgia. The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research 2009; 69(7): 3021 doi: 10.1158/0008-5472.CAN-08-2881
|
| 14 |
Olorunseun O. Ogunwobi, William Puszyk, Hui-Jia Dong, Chen Liu, William B. Coleman. Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma. PLoS ONE 2013; 8(5): e63765 doi: 10.1371/journal.pone.0063765
|
| 15 |
Yan Zhang, Mei-Yu Hu, Wei-Zhong Wu, Zhi-Jun Wang, Kang Zhou, Xi-Liang Zha, Kang-Da Liu. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. Journal of Cancer Research and Clinical Oncology 2006; 132(11): 685 doi: 10.1007/s00432-006-0117-5
|
| 16 |
Judy E Anderson, Ashley C Wozniak. Satellite cell activation on fibers: modeling events in vivo — an invited review. Canadian Journal of Physiology and Pharmacology 2004; 82(5): 300 doi: 10.1139/y04-020
|
| 17 |
Ning Chen, Wei Sun, Xinyu Deng, Yunwei Hao, Xilin Chen, Baocai Xing, Wei Jia, Jie Ma, Handong Wei, Yunping Zhu, Xiaohong Qian, Ying Jiang, Fuchu He. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. PROTEOMICS 2008; 8(23-24): 5108 doi: 10.1002/pmic.200800280
|
| 18 |
Hidetaka Miyagi, Sara M. Thomasy, Paul Russell, Christopher J. Murphy. The role of hepatocyte growth factor in corneal wound healing. Experimental Eye Research 2018; 166: 49 doi: 10.1016/j.exer.2017.10.006
|
| 19 |
Haiyu Wang, Benchen Rao, Jiamin Lou, Jianhao Li, Zhenguo Liu, Ang Li, Guangying Cui, Zhigang Ren, Zujiang Yu. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00055
|
| 20 |
Olorunseun O. Ogunwobi, Chen Liu. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clinical & Experimental Metastasis 2011; 28(8): 721 doi: 10.1007/s10585-011-9404-x
|
| 21 |
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
|
| 22 |
Wei Ding, Hanning You, Hien Dang, Francis LeBlanc, Vivian Galicia, Shelly C. Lu, Bangyan Stiles, C. Bart Rountree. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 2010; 52(3): 945 doi: 10.1002/hep.23748
|
| 23 |
Shenjun Yuan, Yuyuan Gong, Ruobing Chen, Juan Du, Hongfeng Zhang, Tao Chen. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Biomedicine & Pharmacotherapy 2020; 132: 110867 doi: 10.1016/j.biopha.2020.110867
|
| 24 |
Cristian Scheau, Ioana Anca Badarau, Constantin Caruntu, Gratiela Livia Mihai, Andreea Cristiana Didilescu, Carolina Constantin, Monica Neagu. Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma. Molecules 2019; 24(13): 2350 doi: 10.3390/molecules24132350
|
| 25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_181-1
|
| 26 |
Blanca Herrera, María García-Álvaro, Silvia Cruz, Peter Walsh, Margarita Fernández, Cesáreo Roncero, Isabel Fabregat, Aránzazu Sánchez, Gareth J. Inman, Matias A. Avila. BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells. PLoS ONE 2013; 8(7): e69535 doi: 10.1371/journal.pone.0069535
|
| 27 |
Mayumi Suzuki, Hidenori Shiraha, Tatsuya Fujikawa, Nobuyuki Takaoka, Naoki Ueda, Yutaka Nakanishi, Kazuko Koike, Akinobu Takaki, Yasushi Shiratori. Des-γ-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma. Journal of Biological Chemistry 2005; 280(8): 6409 doi: 10.1074/jbc.M406714200
|
| 28 |
Nadia Lasagna, Ornella Fantappiè, Michela Solazzo, Lucia Morbidelli, Serena Marchetti, Greta Cipriani, Marina Ziche, Roberto Mazzanti. Hepatocyte Growth Factor and Inducible Nitric Oxide Synthase Are Involved in Multidrug Resistance–Induced Angiogenesis in Hepatocellular Carcinoma Cell Lines. Cancer Research 2006; 66(5): 2673 doi: 10.1158/0008-5472.CAN-05-2290
|
| 29 |
Toru Beppu, Kensuke Yamamura, Hirohisa Okabe, Katsunori Imai, Hiromitsu Hayashi. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Annals of Gastroenterological Surgery 2021; 5(3): 287 doi: 10.1002/ags3.12414
|
| 30 |
Xin Yang, Xiao-Fei Zhang, Xu Lu, Hu-Liang Jia, Lei Liang, Qiong-Zhu Dong, Qing-Hai Ye, Lun-Xiu Qin. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology 2014; 59(5): 1874 doi: 10.1002/hep.26941
|
| 31 |
Sapana Sameer Chaudhary, Sameer Choudhary, Sakshi Rawat, Gouri Ahir, Anwar L. Bilgrami, Ghulam Md Ashraf. Cancer-Leading Proteases. 2020; : 295 doi: 10.1016/B978-0-12-818168-3.00011-5
|